Billiontoone (NASDAQ:BLLN) SVP Sells 1,417 Shares of Stock

by · The Cerbat Gem

Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) SVP Bosch John Roderick Ten sold 1,417 shares of the company’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $100.00, for a total value of $141,700.00. Following the completion of the transaction, the senior vice president owned 26,467 shares in the company, valued at $2,646,700. This represents a 5.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

  • On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total transaction of $131,582.62.
  • On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $120.00, for a total value of $169,920.00.
  • On Monday, June 15th, Bosch John Roderick Ten sold 2,832 shares of Billiontoone stock. The stock was sold at an average price of $101.47, for a total value of $287,363.04.

Billiontoone Trading Down 1.1%

Billiontoone stock traded down $1.07 during mid-day trading on Thursday, reaching $95.15. 670,193 shares of the company traded hands, compared to its average volume of 841,632. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. Billiontoone, Inc. has a 52-week low of $61.96 and a 52-week high of $150.44. The firm has a market capitalization of $4.49 billion and a price-to-earnings ratio of 137.46. The firm’s 50 day moving average price is $115.34 and its 200 day moving average price is $95.29.

Billiontoone (NASDAQ:BLLN – Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The firm had revenue of $109.45 million for the quarter. On average, analysts anticipate that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Institutional Trading of Billiontoone

Several hedge funds have recently bought and sold shares of the stock. Rossby Financial LCC purchased a new position in shares of Billiontoone during the 4th quarter valued at about $25,000. Wells Fargo & Company MN bought a new position in shares of Billiontoone in the fourth quarter worth about $76,000. Smartleaf Asset Management LLC purchased a new stake in Billiontoone during the 4th quarter valued at approximately $80,000. Nano Cap New Millennium Growth Fund L P purchased a new position in Billiontoone during the fourth quarter valued at $82,000. Finally, Thrive Wealth Management LLC bought a new stake in shares of Billiontoone in the second quarter worth about $240,000.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on BLLN. Guggenheim assumed coverage on Billiontoone in a report on Monday, June 29th. They set a “buy” rating and a $125.00 target price on the stock. Wall Street Zen cut shares of Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. JPMorgan Chase & Co. dropped their target price on Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a report on Thursday, August 6th. Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, June 23rd. Finally, BTIG Research reduced their price objective on Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a report on Thursday, August 6th. Six equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $126.71.

Get Our Latest Report on BLLN

About Billiontoone

(Get Free Report)

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.

Recommended Stories